Attendance at a breast screening clinic: a problem of administration or attitudes.

French, Kate Rollert; Porter, Anthony; Robinson, Susan E.; McCallum, Farzana; Howie, J. G. R.; Roberts, M M

doi:10.1136/bmj.285.6342.617

Cited by 90 publications

(24 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is evidence that those who seek consultation quickly have lives that are less busy and stress-filled (Burgess et al, 2000). The breast cancer screening literature also finds that difficulties related to family or work are a common reason that women give for not attending breast screening (French et al, 1982).…”

Section: Discussionmentioning

confidence: 99%

Causes of Delay in Seeking Treatment in Patients with Breast Cancer in Iran: a Qualitative Content Analysis Study

Rastad¹,

Khanjani²,

Khandani³

2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: In the Middle East, including Iran, breast cancer is the most frequent malignancy among women. Without treatment, a malignant breast tumor advances in stage, diminishing a woman's chances of survival. In this study we aimed to gain insight into the causes of delay in seeking treatment in patients with breast cancer. Methods: The participants in this qualitative, content analysis study were 10 women in whom a diagnosis of breast cancer in the stages of II b, III or IIV had been made. They were selected from patients of a major oncology clinic in Kerman, Iran. Data were collected by means of semi-structured interviews that lasted between 20 to 30 minutes. Sampling was discontinued when data saturation was achieved. Content analysis was conducted by classifying the data into themes and sub-themes. Results: The results of our study revealed several factors that interfered with patients' professional consultation seeking and prompt treatment. These factors included; lack of knowledge, fear of being diagnosed with cancer, not seeing oneself at risk, mental preoccupation and wrong diagnosis by physicians. Conclusions: This study suggests that women and even physicians need further information about breast cancer symptoms. Women need encouragement to seek medical advice when they encounter suspicious symptoms. Additionally, women may benefit from awareness of the pros of early detection and reassurance about the improvements in the success of breast cancer treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Causes of Delay in Seeking Treatment in Patients with Breast Cancer in Iran: a Qualitative Content Analysis Study

Rastad¹,

Khanjani²,

Khandani³

2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…In the context of breast screening non-attenders have been reported to exaggerate difficulties such as home and work commitments." 45 …”

Section: Effort Attending Assessment (Factor 4)mentioning

confidence: 99%

Breast Screening: Adverse Psychological Consequences One Month after Placing Women on Early Recall Because of a Diagnostic Uncertainty. A Multicentre Study

Ong¹,

Austoker²,

Brett³

1997

J Med Screen

View full text Add to dashboard Cite

Background-It was the original intention of the UK National Health Service Breast Screening Programme (NHSBSP) to place women who were not diagnosed with cancer on three yearly routine recall (RR). In 1994-5 approximately 16500 women, aged 50 to 64, were placed on early recall (ER) at a shorter time interval, of which about 98% will have a normal result. This large number exceeds the expectations of the NHSBSP. Objective-To establish the adverse psychological consequences (PCs) for women one month after placement on ER because of a diagnostic uncertainty, and if detected, to suggest practical solutions to reduce them. Methods-Thirteen breast screening centres throughout the UK participated in the study. From March to October 1995 all women who were placed on ER because of a diagnostic uncertainty were identified and compared with groups of women placed on RR (after mammography, assessment, fine needle aspiration, and a benign biopsy). These women were invited to complete a postal questionnaire one month after they were placed on ER or RR. One reminder was sent. Results-Overall 75% of women completed the questionnaire. The adverse PCs of placing women on ER because of a diagnostic uncertainty were higher (63%; n=81 of 130) than those of women placed on RR after mammography (29%; n=38 of 130) (P<0.00001) or assessment (50%; n=64 of 128)(P<0.05), but lower than the adverse PCs of women who underwent a benign biopsy (87%; n=26 of 30)(P<0.05). Factors that were significantly associated with subsequent adverse PCs were identified. Conclusions-The adverse PCs of being placed on ER because of a diagnostic uncertainty were significantly higher than those of women who turned out to have a false-positive mammographic result after assessment. Possible practical solutions are discussed.

show abstract

“…Ten of the papers showed a significant positive association between the two screening behaviours, such that those who have participated in breast screening are more likely also to attend for cervical screening, 87,118,144,[158][159][160][161][162][163][164] and the remaining two showed no association.…”

Section: Cervical Screening Practicesmentioning

confidence: 99%

“…Ten out of 12 papers found positive associations between mammography use and health prevention behaviours but, again, none of these studies had baseline measures so the direction of the association cannot be ascertained. 87,118,133,146,[158][159][160][161]164,172 Two studies reported no association. 123,136 One study found positive associations between mammography and tetanus immunisation, sigmoidoscopy screening and faecal occult blood testing, but no associations between breast screening and smoking behaviours, exercise, seatbelt use, aspirin or hormone replacement therapy (HRT) use.…”

Section: Other Preventive Health Behavioursmentioning

confidence: 99%

The impact of screening on future health-promoting behaviours and health beliefs: a systematic review

Bankhead

Brett²,

Bukach³

et al. 2003

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.Initially, six HTA panels (pharmaceuticals, acute sector, primary and community care, diagnostics and imaging, population screening, methodology) helped to set the research priorities for the HTA Programme. However, during the past few years there have been a number of changes in and around NHS R&D, such as the establishment of the National Institute for Clinical Excellence (NICE) and the creation of three new research programmes: Service Delivery and Organisation (SDO); New and Emerging Applications of Technology (NEAT); and the Methodology Programme.This has meant that the HTA panels can now focus more explicitly on health technologies ('health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care) rather than settings of care. Therefore the panel structure was replaced in 2000 by three new panels: Pharmaceuticals; Therapeutic Procedures (including devices and operations); and Diagnostic Technologies and Screening.The HTA Programme will continue to commission both primary and secondary research. The HTA Commissioning Board, supported by the National Coordinating Centre for Health Technology Assessment (NCCHTA...

show abstract

Attendance at a breast screening clinic: a problem of administration or attitudes.

Cited by 90 publications

References 10 publications

Causes of Delay in Seeking Treatment in Patients with Breast Cancer in Iran: a Qualitative Content Analysis Study

Causes of Delay in Seeking Treatment in Patients with Breast Cancer in Iran: a Qualitative Content Analysis Study

Breast Screening: Adverse Psychological Consequences One Month after Placing Women on Early Recall Because of a Diagnostic Uncertainty. A Multicentre Study

The impact of screening on future health-promoting behaviours and health beliefs: a systematic review

Contact Info

Product

Resources

About